Načítá se...

Desialylation of dying cells with catalytically active antibodies possessing sialidase activity facilitate their clearance by human macrophages

Recently we reported the first known incidence of antibodies possessing catalytic sialidase activity (sialidase abzymes) in the serum of patients with multiple myeloma and systemic lupus erythematosus (SLE). These antibodies desialylate biomolecules, such as glycoproteins, gangliosides and red blood...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Clin Exp Immunol
Hlavní autoři: Tomin, A, Dumych, T, Tolstyak, Y, Kril, I, Mahorivska, I, Bila, E, Stoika, R, Herrmann, M, Kit, Y, Bilyy, R
Médium: Artigo
Jazyk:Inglês
Vydáno: Blackwell Science Inc 2015
Témata:
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC4260892/
https://ncbi.nlm.nih.gov/pubmed/24580640
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/cei.12312
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!